InvestorsHub Logo
Followers 23
Posts 1018
Boards Moderated 0
Alias Born 07/01/2009

Re: None

Wednesday, 08/14/2013 10:01:32 AM

Wednesday, August 14, 2013 10:01:32 AM

Post# of 766
BNLB News...Bond Labs Reports 2nd Quarter and YTD Results
Impressive Domestic and
International Growth Trends Continue


OMAHA, Neb., Aug 14, 2013 (BUSINESS WIRE) -- Bond Laboratories, Inc.
(OTCBB:BNLB) ("Bond Labs"),
a national provider of innovative and proprietary nutritional supplements for
health conscious consumers, today announced significant continued core business
revenue growth and positive net income for the second fiscal quarter and
year-to-date results.

Revenue for the three months ended June 30, 2013 was $5.1 million as compared to
$5.2 million for the comparable period in 2012, a decrease of 2.3%. Revenue for
the six months ended June 30, 2013 was $11.1 million as compared to $10.1
million for the comparable period in 2012, an increase of 9.7%. Revenue for the
three and six month periods ended June 30, 2012 included $0.8 million and $1.6
million of non-recurring revenue, respectively, primarily related to the sell
through of certain products containing DMAA, an established and widely used
ingredient that experienced increased scrutiny from the FDA. Excluding
non-recurring revenue related to products containing DMAA that were reformulated
during 2012, revenue for the three and six month periods ended June 30, 2013
increased 14.5% and 30.7%, respectively, as compared to the comparable periods
in 2012.

Net income for the three and six month periods ended June 30, 2013 was $0.5
million and $1.1 million, respectively, as compared to $0.8 million and $1.5
million, respectively, for the comparable periods in 2012. In addition to
approximately $0.3 million of incremental non-cash issuance costs incurred
during the first half of 2013 over the comparable period in 2012 and the impact
of the non-recurring DMAA activity from 2012, net income for the three and six
months periods ended June 30, 2013 reflect ongoing investment by the Company to
enhance its sales and marketing efforts, which management believes will drive
future domestic and international growth.

During the six month period ended June 30, 2013, Bond Labs generated $1.5
million of cash flow from operations as compared to $0.3 million for the
comparable six-month period ended June 30, 2012.

"With the recent introduction of our new SirenLabs
line, Bond Labs now boasts three high-quality product lines exclusive to the GNC
franchise system: NDS, PMD Sports Nutrition and SirenLabs. Strong brand
awareness, a high-quality reputation and commitment to providing our customers
with innovative and truly differentiated solutions continue to be the primary
drivers behind our success both domestically and
internationally," stated John S. Wilson, Chief
Executive Officer of Bond Labs. "International
expansion remains a critical element of our future growth plan. We now sell a
subset of our total product portfolio in eight of the approximately fifty
countries with GNC locations. Our growth strategy is focused on both expanding
the number of countries in Bond Labs' distribution
footprint as well as increasing the average number of SKUs sold through each
country. It is truly an exciting time at the company and I look forward to
continuing to execute our growth plan to expand the business and create
shareholder value," concluded Mr. Wilson.

About Bond Labs

Bond Laboratories is a manufacturer of innovative and proprietary nutritional
supplements for health conscious consumers. The Company produces and markets
products through its NDS Nutrition division. NDS'
products number over 60 brands of energy, sports, and dietary supplements. These
products are sold directly through specialty health and nutrition retailers, and
are included among the top-selling products at GNC(R) franchises.
Bond Labs is headquartered in Omaha, Nebraska. For more information, please
visit http://www.bond-labs.com.

Safe Harbor

Statements about the Company's future expectations
and all other statements in this press release other than historical facts, are
"forward-looking
statements" within the meaning of Section 27A of the
Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and
as that term is defined in the Private Securities Litigation Reform Act of 1995.
The Company intends that such forward-looking statements be subject to the safe
harbors created thereby. The above information contains information relating to
the Company that is based on the beliefs of the Company and/or its management as
well as assumptions made by and information currently available to the Company
or its management. The company does not undertake any responsibility to update
the forward-looking statements contained in this release.


http://cts.businesswire.com/ct/CT?id=bwnews&sty=20130814005347r1&sid=cmtx6&distro=nx

SOURCE: Bond Laboratories, Inc.



CONTACT:
Surety Financial Group, LLC
Bruce Weinstein, 410-833-0078




Copyright Business Wire 2013

-0-




KEYWORD: United States

North America

Nebraska

INDUSTRY KEYWORD: Health

Fitness & Nutrition

Retail

Specialty

SUBJECT CODE: Earnings
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y